Zoetis ZTS Fish — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Zoetis in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zoetis's fish — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Zoetis's fish — revenue?
- Zoetis (ZTS) reported fish — revenue of $66M in Q1 2026.
- How has Zoetis's fish — revenue changed year-over-year?
- Zoetis's fish — revenue increased by 20.0% year-over-year, from $55M to $66M.
- What is the long-term trend for Zoetis's fish — revenue?
- Over 4 years (2021 to 2025), Zoetis's fish — revenue has grown at a 11.4% compound annual growth rate (CAGR), from $187M to $288M.
- What does fish — revenue mean?
- This metric represents the total gross sales generated from the company's portfolio of health products specifically designed for the aquaculture and fish farming industry. It encompasses revenue from vaccines, parasiticides, and other therapeutic treatments used to manage the health and productivity of farmed aquatic species. This segment reflects the company's exposure to the global aquaculture market and its ability to capture demand for specialized aquatic health solutions.